-
Mashup Score: 4ACC.24: Coronary sinus reducer for the treatment of refractory angina: A randomised, placebo-controlled trial (ORBITA-COSMIC) - 1 month(s) ago
Aaysha Cader interviews Michael Foley and Rasha Al-Lamee about the results of the ORBITA-COSMIC trial presented at ACC 2024. Results showed that coronary sinus reducer relieved angina symptoms but lacked evidence of increased blood flow to the heart. While beneficial for refractory angina patients, its mechanism remains unclear.
Source: www.pcronline.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Rates of Elective Percutaneous Coronary Intervention in England and Wales: Impact of COURAGE and ORBITA Trials - 2 year(s) ago
Background There are limited data about how COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) and ORBITA (Objective Randomized Blinded Investigation With Optima…
Categories: Cardiologists, Latest HeadlinesTweet-
Has #Orbita or #Courage impacted on elective PCI in the UK? our work led by @drrashid05 suggests no! ➡️ https://t.co/ymD0nEJAdN @hwijeysundera @ncurzen @DrAsifQasim @rwyeh @SVRaoMD @GreggWStone @ShelleyWood2 @DavidLBrownMD @alaide_chief @ShrillaB @mirvatalasnag @cardiojaydoc02 https://t.co/jqahV98yyW
-
-
Mashup Score: 11Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial - 2 year(s) ago
AbstractAims. Oxygen-pulse morphology and gas exchange analysis measured during cardiopulmonary exercise testing (CPET) has been associated with myocardial isch
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
CPET and efficacy of #PCI :A substudy of the #ORBITA trial In 195 pts, an O2-pulse plateau was associated with more ischaemia on stress-echo and FFR while other impaired PET parameters were associated with greater symptom burden https://t.co/oLg28u5wUV @ESC_Journals #EchoFirst https://t.co/KtrMzNXLPR
-
-
Mashup Score: 1
Background In stable coronary artery disease, medications are used for 2 purposes: cardiovascular risk reduction and symptom improvement. In clinical trials and clinical practice, medication use is…
Categories: Cardiology News and Journals, Latest HeadlinesTweet-
Optimal medical therapy can be achieved in the majority of stable angina: results from the #ORBITA trial. https://t.co/iH4tJEui1F @MikeFoley89 @rallamee @ImperialNHLI #AHAJournals https://t.co/sNRHBqDFBc
-
-
Mashup Score: 3Events | Live Case #22 Complex Protected PCI - 3 year(s) ago
Live Cases Live Case #22 Complex Protected PCI Live Cases · Live Case #22 Complex Protected PCI Live Case #22 Complex Protected PCI Wed, Jan 27, 2021 at 4:00 pm Eastern Time Event starts in This event is not open for public registration. Please…
Source: camppci.orgCategories: Cardiologists, Latest HeadlinesTweet-
Finish your cases today before 4 pm & join https://t.co/hKcbJmnsbM @ziadalinyc & @DrAllenJ live from @StFrancis_LI Panelists @duanepinto @DrAmirKaki @PaulTeirstein Impressive progression of coronary disease in 15 mo LAD CTO- we're sure to hear about #COURAGE #ISCHEMIA #ORBITA https://t.co/X23daSuNsN
-
-
Mashup Score: 0
URL: https://www.clinicaltrials.gov. Unique identifier: NCT02062593.
Source: PubMedCategories: CardiologistsTweet-
@MKIttlesonMD I wish #ORBITA had SPECT data. But extrapolating from stress echo data, it seems that the larger the territory at risk, the more likely their symptoms will be relieved by PCI https://t.co/mMdbnn3iNy I would’ve proceeded with an angio +- PCI. But adding nitro is acceptable.
-
-
Mashup Score: 0
Background: Dobutamine stress echocardiography is widely used to test for ischemia in patients with stable coronary artery disease. In this analysis, we studied the ability of the prerandomization …
Source: www.ahajournals.orgCategories: CardiologistsTweet-
@EGarciaSayan @ASE360 @pattypellikka @iamritu @DavidWienerMD Looking forward to see. Will love comments on recent placebo controlled #ORBITA sub study with stress echo by @rallamee et al https://t.co/rf0dJhnSEC I think we need more placebo controlled trials to also assess possible clinical value of the stress imaging techniques we use.
-
RT @aayshacader: @PCRonline coverage of #ORBITA- COSMIC - Impact of CSR on pts with refractory angina 🎥 https://t.co/cE1mvhVl6a @TheLanc…